ROCKVILLE, Md.— New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past ...

SILVER SPRING, Md.--President-elect of The Obesity Society (TOS) Lee M. Kaplan, MD, PhD, FTOS, has co-authored a new study that describes a newly developed genetic test that can identify newborns at ...

ROCKVILLE, Md., Nov. 14, 2023 /PRNewswire/ -- New findings show that the medication known as Wegovy ® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a ...

ROCKVILLE, Md., Nov. 14, 2023 /PRNewswire/ -- New findings show that the medication known as Wegovy ® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a ...